Financials
Financial year 2025
MEDLEG from Fleurus, company number BE0865546341, closed financial year 2025 with a result of € 206,081 after tax. For that financial year MEDLEG recorded a gross margin of € 317,012 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 251,059 to € 206,081. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 1.2 million
▼ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 206,081
▼ 18% vs 2024
Profit after tax over the fiscal year.
€ 120,168
▼ 41% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 255,367 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 93,070
▼ 22% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 44,134
▼ 20% vs 2024
€ 11,722 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 34,930
▲ € 26,338 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 30,003
▼ 45% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 307,784 | € 303,253 | € 368,761 | € 317,012 | ▼ 14% |
| Profit after taxes | € 190,750 | € 191,647 | € 251,059 | € 206,081 | ▼ 18% |
| Equity | € 799,443 | € 991,089 | € 1,242,149 | € 1,192,863 | ▼ 4% |
| Total debts | € 297,256 | € 89,926 | € 121,097 | € 110,634 | ▼ 9% |
| Cash | € 503,550 | € 105,087 | € 204,179 | € 120,168 | ▼ 41% |
| Retained profit | € 787,043 | € 978,689 | € 1,229,749 | € 1,180,463 | ▼ 4% |
| Dividend | € 191,043 | € 0 | € 0 | € 255,367 | |
| Bank debt | € 33,799 | € 22,967 | € 55,421 | € 44,134 | ▼ 20% |
| Balance sheet total | € 1,096,698 | € 1,081,015 | € 1,363,245 | € 1,303,496 | ▼ 4% |
Key figures of MEDLEG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about MEDLEG the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to MEDLEG?
What happened at MEDLEG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 206,081 (▼ 18% vs 2024). filed late Source: NBB ↗
- ALAIN DUVERGER became a director. NBB
- New establishment in Fleurus. KBO
- New establishment in Charleroi. KBO
- Start of the company according to the CBE. KBO
In short
From € 190,750 profit in 2022 to € 206,081 profit in 2025.
Paid € 372,758 in corporate taxes since 2022.
Best year ever: 2024, with € 251,059 profit.
Paid out € 446,409 in dividends to the owners in total.
Management
Behind MEDLEG is ALAIN DUVERGER. ALAIN DUVERGER is also behind EXMED.
Directors
According to the 2025 annual accounts
since 2023
Establishments
Establishment units
Physical locations of this company
Avenue du Premier Empire(FL) 8
6220 Fleurus
Rue Emile Tumelaire 43/5
6000 Charleroi
Active since 1 June 2004
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0865.546.341
- VAT number
- BE 0865.546.341
- Registered office
- Avenue du Premier Empire(FL) 8, 6220 Fleurus
- Names & denominations
- MEDLEG
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 June 2004
- Peppol
- Active · Active since 27 Nov 2025
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten